Literature DB >> 24700873

Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD.

Rafael Kramann1, Johanna Erpenbeck2, Rebekka K Schneider3, Anna B Röhl4, Marc Hein4, Vincent M Brandenburg5, Merel van Diepen6, Friedo Dekker6, Nicolaus Marx5, Jürgen Floege2, Michael Becker5, Georg Schlieper2.   

Abstract

Cardiovascular mortality is high in ESRD, partly driven by sudden cardiac death and recurrent heart failure due to uremic cardiomyopathy. We investigated whether speckle-tracking echocardiography is superior to routine echocardiography in early detection of uremic cardiomyopathy in animal models and whether it predicts cardiovascular mortality in patients undergoing dialysis. Using speckle-tracking echocardiography in two rat models of uremic cardiomyopathy soon (4-6 weeks) after induction of kidney disease, we observed that global radial and circumferential strain parameters decreased significantly in both models compared with controls, whereas standard echocardiographic readouts, including fractional shortening and cardiac output, remained unchanged. Furthermore, strain parameters showed better correlations with histologic hallmarks of uremic cardiomyopathy. We then assessed echocardiographic and clinical characteristics in 171 dialysis patients. During the 2.5-year follow-up period, ejection fraction and various strain parameters were significant risk factors for cardiovascular mortality (primary end point) in a multivariate Cox model (ejection fraction hazard ratio [HR], 0.97 [95% confidence interval (95% CI), 0.95 to 0.99; P=0.012]; peak global longitudinal strain HR, 1.17 [95% CI, 1.07 to 1.28; P<0.001]; peak systolic and late diastolic longitudinal strain rates HRs, 4.7 [95% CI, 1.23 to 17.64; P=0.023] and 0.25 [95% CI, 0.08 to 0.79; P=0.02], respectively). Multivariate Cox regression analysis revealed circumferential early diastolic strain rate, among others, as an independent risk factor for all-cause mortality (secondary end point; HR, 0.43; 95% CI, 0.25 to 0.74; P=0.002). Together, these data support speckle tracking as a postprocessing echocardiographic technique to detect uremic cardiomyopathy and predict cardiovascular mortality in ESRD.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Year:  2014        PMID: 24700873      PMCID: PMC4178432          DOI: 10.1681/ASN.2013070734

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  66 in total

1.  2D-speckle tracking echocardiography contributes to early identification of impaired left ventricular myocardial function in patients with chronic kidney disease.

Authors:  Ping Yan; Haiming Li; Chuanming Hao; Haiming Shi; Yong Gu; Guoqian Huang; Jing Chen
Journal:  Nephron Clin Pract       Date:  2010-12-24

Review 2.  Risk assessment for sudden cardiac death in dialysis patients.

Authors:  Palaniappan Saravanan; Neil C Davidson
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-10

Review 3.  Sudden cardiac death in hemodialysis patients: an in-depth review.

Authors:  Darren Green; Paul R Roberts; David I New; Philip A Kalra
Journal:  Am J Kidney Dis       Date:  2011-04-15       Impact factor: 8.860

4.  Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus.

Authors:  Arnold C T Ng; Victoria Delgado; Matteo Bertini; Rutger W van der Meer; Luuk J Rijzewijk; See Hooi Ewe; Hans-Marc Siebelink; Johannes W A Smit; Michaela Diamant; Johannes A Romijn; Albert de Roos; Dominic Y Leung; Hildo J Lamb; Jeroen J Bax
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

5.  Left ventricular systolic strain in chronic kidney disease and hemodialysis patients.

Authors:  Yen-Wen Liu; Chi-Ting Su; Yao-Yi Huang; Chun-Shin Yang; Jenq-Wen Huang; Mao-Ting Yang; Jyh-Hong Chen; Wei-Chuan Tsai
Journal:  Am J Nephrol       Date:  2010-12-17       Impact factor: 3.754

6.  Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells.

Authors:  Rafael Kramann; Simone K Couson; Sabine Neuss; Uta Kunter; Manfred Bovi; Jörg Bornemann; Ruth Knüchel; Willi Jahnen-Dechent; Jürgen Floege; Rebekka K Schneider
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-16       Impact factor: 8.311

7.  Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart.

Authors:  Erik B Schelbert; Li-Yueh Hsu; Stasia A Anderson; Bibhu D Mohanty; Syed M Karim; Peter Kellman; Anthony H Aletras; Andrew E Arai
Journal:  Circ Cardiovasc Imaging       Date:  2010-09-16       Impact factor: 7.792

Review 8.  Uremic cardiomyopathy and insulin resistance: a critical role for akt?

Authors:  David Semple; Katie Smith; Sunil Bhandari; Anne-Marie L Seymour
Journal:  J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 10.121

9.  High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.

Authors:  Karin Tyralla; Marcin Adamczak; Kerstin Benz; Valentina Campean; Marie-Luise Gross; Karl F Hilgers; Eberhard Ritz; Kerstin Amann
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

10.  Speckle-tracking 2-dimensional strain echocardiography: a new noninvasive imaging tool to evaluate acute rejection in cardiac transplantation.

Authors:  Galen M Pieper; Akash Shah; Leanne Harmann; Brian C Cooley; Irina A Ionova; Raymond Q Migrino
Journal:  J Heart Lung Transplant       Date:  2010-05-20       Impact factor: 13.569

View more
  40 in total

1.  Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort.

Authors:  Ruth F Dubin; Rajat Deo; Nisha Bansal; Amanda H Anderson; Peter Yang; Alan S Go; Martin Keane; Ray Townsend; Anna Porter; Matthew Budoff; Shaista Malik; Jiang He; Mahboob Rahman; Jackson Wright; Thomas Cappola; Radhakrishna Kallem; Jason Roy; Daohang Sha; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-10       Impact factor: 8.237

2.  Longitudinal assessment of myocardial function in childhood chronic kidney disease, during dialysis, and following kidney transplantation.

Authors:  Rawan K Rumman; Ronand Ramroop; Rahul Chanchlani; Mikaeel Ghany; Diane Hebert; Elizabeth A Harvey; Rulan S Parekh; Luc Mertens; Michael Grattan
Journal:  Pediatr Nephrol       Date:  2017-03-08       Impact factor: 3.714

3.  Effects of obesity and metabolic syndrome on cardiovascular outcomes in pediatric kidney transplant recipients: a longitudinal study.

Authors:  Kristen Sgambat; Sarah Clauss; K Y Lei; Jiuzhou Song; Shaik O Rahaman; Margaret Lasota; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2017-12-30       Impact factor: 3.714

Review 4.  Cardiovascular disease in patients with chronic kidney disease.

Authors:  Turgay Saritas; Jürgen Floege
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

5.  Associations of Macro- and Microvascular Endothelial Dysfunction With Subclinical Ventricular Dysfunction in End-Stage Renal Disease.

Authors:  Ruth F Dubin; Isabella Guajardo; Amrita Ayer; Claire Mills; Catherine Donovan; Lauren Beussink; Rebecca Scherzer; Peter Ganz; Sanjiv J Shah
Journal:  Hypertension       Date:  2016-08-22       Impact factor: 10.190

6.  Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction.

Authors:  Ling Lin; Qiuxia Xie; Mei Zheng; Xuhui Zhou; Ilona A Dekkers; Qian Tao; Hildo J Lamb
Journal:  Eur Radiol       Date:  2021-02-24       Impact factor: 5.315

7.  Speckle tracking determination of mitral tissue annular displacement: comparison with strain and ejection fraction, and association with outcomes in haemodialysis patients.

Authors:  Diana Y Y Chiu; Nik Abidin; John Hughes; Smeeta Sinha; Philip A Kalra; Darren Green
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-27       Impact factor: 2.357

8.  Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.

Authors:  Erin D Unger; Ruth F Dubin; Rajat Deo; Vistasp Daruwalla; Julie L Friedman; Crystal Medina; Lauren Beussink; Benjamin H Freed; Sanjiv J Shah
Journal:  Eur J Heart Fail       Date:  2015-12-03       Impact factor: 15.534

Review 9.  Soluble Guanylate Cyclase Stimulators: a Novel Treatment Option for Heart Failure Associated with Cardiorenal Syndromes?

Authors:  Ruth F Dubin; Sanjiv J Shah
Journal:  Curr Heart Fail Rep       Date:  2016-06

10.  Cardiac dysfunction in Pkd1-deficient mice with phenotype rescue by galectin-3 knockout.

Authors:  Bruno E Balbo; Andressa G Amaral; Jonathan M Fonseca; Isac de Castro; Vera M Salemi; Leandro E Souza; Fernando Dos Santos; Maria C Irigoyen; Feng Qian; Roger Chammas; Luiz F Onuchic
Journal:  Kidney Int       Date:  2016-07-27       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.